Sara Weymer

Technik-/Wissenschafts-/F&E-Leiter bei BOUNDLESS BIO, INC.

Health Technology

Aktive Positionen von Sara Weymer

Unternehmen	Position	Beginn	Ende
BOUNDLESS BIO, INC.	Technik-/Wissenschafts-/F&E-Leiter	04.06.2022	-
ZZ Biotech LLC ZZ Biotech LLC BiotechnologyHealth Technology ZZ Biotech LLC operates as a clinical stage company. It develops biologic treatments for ischemic stroke and other neurological diseases and wound healing applications including the treatment of diabetic foot ulcers. The firm mainly focuses on developing 3K3A-APC, a novel second-generation variant of a naturally occurring human protein licensed from The Scripps Research Institute. The company was founded by Selim Zilkha and Berislav V. Zlokovic in 2006 and is headquartered in Houston, TX.	Corporate Officer/Principal	-	-

Unternehmen	Position	Beginn	Ende
FATE THERAPEUTICS, INC.	Direktor/Vorstandsmitglied	-	-
FATE THERAPEUTICS, INC.	Corporate Officer/Principal	-	-

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	2
Chief Tech/Sci/R&D Officer	1
Director/Board Member	1

Sektoral

Health Technology

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
BOUNDLESS BIO, INC.	Health Technology
FATE THERAPEUTICS, INC.	Health Technology

Private Unternehmen	1
ZZ Biotech LLC ZZ Biotech LLC BiotechnologyHealth Technology ZZ Biotech LLC operates as a clinical stage company. It develops biologic treatments for ischemic stroke and other neurological diseases and wound healing applications including the treatment of diabetic foot ulcers. The firm mainly focuses on developing 3K3A-APC, a novel second-generation variant of a naturally occurring human protein licensed from The Scripps Research Institute. The company was founded by Selim Zilkha and Berislav V. Zlokovic in 2006 and is headquartered in Houston, TX.	Health Technology

Private Unternehmen

Health Technology